NovoTTF-200T(P)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NovoTTF-200T(P), covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma [Phase 2]